Consistent with these results, the proportion of tumor cells in the ascites of CD8-depleted mice was significantly higher than that of non-depleted or NK-depleted mice after treated with VV-α-TIGIT (P <0.001; P <0.05) (Fig. 7D). The gene discussed is CD8A; the disease is neoplasm.